Model program used in paper in Lancet Global Health entitled Potential cost-effectiveness of community availability of tenofovir-lamivudine-dolutegravir for HIV prevention and treatment in East, Central, Southern and West Africa: a modelling analysis
Includes the model program itself and the program to analyse model outputs.
Date made available | 1 Sept 2023 |
---|
Publisher | tbc |
---|